These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27584594)

  • 1. Automatically updating predictive modeling workflows support decision-making in drug design.
    Muegge I; Bentzien J; Mukherjee P; Hughes RO
    Future Med Chem; 2016 Sep; 8(14):1779-96. PubMed ID: 27584594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discovery FAQs: workflows for answering multidomain drug discovery questions.
    Chichester C; Digles D; Siebes R; Loizou A; Groth P; Harland L
    Drug Discov Today; 2015 Apr; 20(4):399-405. PubMed ID: 25463038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
    Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
    Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive Workflow: novel software architecture for automating drug design.
    Cartmell J; Krstajic D; Leahy DE
    Curr Opin Drug Discov Devel; 2007 May; 10(3):347-52. PubMed ID: 17554862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of mathematical model predictions into routine workflows to support clinical decision making in haematology.
    Hoffmann K; Cazemier K; Baldow C; Schuster S; Kheifetz Y; Schirm S; Horn M; Ernst T; Volgmann C; Thiede C; Hochhaus A; Bornhäuser M; Suttorp M; Scholz M; Glauche I; Loeffler M; Roeder I
    BMC Med Inform Decis Mak; 2020 Feb; 20(1):28. PubMed ID: 32041606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modeling workflow that balances automation and human intervention to inform invasive plant management decisions at multiple spatial scales.
    Young NE; Jarnevich CS; Sofaer HR; Pearse I; Sullivan J; Engelstad P; Stohlgren TJ
    PLoS One; 2020; 15(3):e0229253. PubMed ID: 32150554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data to Decisions: Creating a Culture of Model-Driven Drug Discovery.
    Brown FK; Kopti F; Chang CZ; Johnson SA; Glick M; Waller CL
    AAPS J; 2017 Sep; 19(5):1255-1263. PubMed ID: 28770387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of employing computational resources for the automation of drug discovery.
    Rosales-Hernández MC; Correa-Basurto J
    Expert Opin Drug Discov; 2015 Mar; 10(3):213-9. PubMed ID: 25682781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Software for rapid prototyping in the pharmaceutical and biotechnology industries.
    Kappler MA
    Curr Opin Drug Discov Devel; 2008 May; 11(3):389-92. PubMed ID: 18428093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR workbench: automating QSAR modeling to drive compound design.
    Cox R; Green DV; Luscombe CN; Malcolm N; Pickett SD
    J Comput Aided Mol Des; 2013 Apr; 27(4):321-36. PubMed ID: 23615761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
    Desai PV; Sawada GA; Watson IA; Raub TJ
    Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of machine learning approaches for novel drug discovery.
    Lima AN; Philot EA; Trossini GH; Scott LP; Maltarollo VG; Honorio KM
    Expert Opin Drug Discov; 2016; 11(3):225-39. PubMed ID: 26814169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the QSAR's predictive truthfulness of the novel N-tuple discrete derivative indices on benchmark datasets.
    Martínez-Santiago O; Marrero-Ponce Y; Vivas-Reyes R; Rivera-Borroto OM; Hurtado E; Treto-Suarez MA; Ramos Y; Vergara-Murillo F; Orozco-Ugarriza ME; Martínez-López Y
    SAR QSAR Environ Res; 2017 May; 28(5):367-389. PubMed ID: 28590848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial QSAR of ambergris fragrance compounds.
    Kovatcheva A; Golbraikh A; Oloff S; Xiao YD; Zheng W; Wolschann P; Buchbauer G; Tropsha A
    J Chem Inf Comput Sci; 2004; 44(2):582-95. PubMed ID: 15032539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
    van de Waterbeemd H
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model Checking for Verification of Interactive Health IT Systems.
    Butler KA; Mercer E; Bahrami A; Tao C
    AMIA Annu Symp Proc; 2015; 2015():349-58. PubMed ID: 26958166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flexible End2End Workflow Automation of Hit-Discovery Research.
    Holzmüller-Laue S; Göde B; Thurow K
    J Lab Autom; 2014 Aug; 19(4):349-61. PubMed ID: 24464814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative structure-activity relationship models that stand the test of time.
    Davis AM; Wood DJ
    Mol Pharm; 2013 Apr; 10(4):1183-90. PubMed ID: 23316903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico prediction of ADME properties: are we making progress?
    Beresford AP; Segall M; Tarbit MH
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):36-42. PubMed ID: 14982146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.